JOE Society for Endocrinology Archive
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1677/joe.0.1720199

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pangas, S.
Right arrow Articles by Woodruff, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pangas, S.
Right arrow Articles by Woodruff, T.
Journal of Endocrinology, Vol 172, Issue 1, 199-210
Copyright © 2002 by Society for Endocrinology


Articles

Production and purification of recombinant human inhibin and activin

SA Pangas and TK Woodruff


Inhibin and activin are protein hormones with diverse physiological roles including the regulation of pituitary FSH secretion. Like other members of the transforming growth factor-beta gene family, they undergo processing from larger precursor molecules as well as assembly into functional dimers. Isolation of inhibin and activin from natural sources can only produce limited quantities of bioactive protein. To purify large-scale quantities of recombinant human inhibin and activin, we have utilized stably transfected cell lines in self-contained bioreactors to produce protein. These cells produce approximately 200 microg/ml per day total recombinant human inhibin. Conditioned cell media can be purified through column chromatography resulting in dimeric mature 32-34 kDa inhibin A and 28 kDa activin A. The purified recombinant proteins maintain their biological activity as measured by traditional in vitro assays including the regulation of FSH in rat anterior pituitary cultures and the regulation of promoter activity of the activin-responsive promoter p3TP-luc in tissue culture cells. These proteins will be valuable for future analysis of inhibin and activin function and have been distributed to the US National Hormone and Peptide Program.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Antenos, J. Zhu, N. M. Jetly, and T. K. Woodruff
An Activin/Furin Regulatory Loop Modulates the Processing and Secretion of Inhibin {alpha}- and {beta}B-Subunit Dimers in Pituitary Gonadotrope Cells
J. Biol. Chem., November 28, 2008; 283(48): 33059 - 33068.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
T.-V. Do, L. A. Kubba, H. Du, C. D. Sturgis, and T. K. Woodruff
Transforming Growth Factor-{beta}1, Transforming Growth Factor-{beta}2, and Transforming Growth Factor-{beta}3 Enhance Ovarian Cancer Metastatic Potential by Inducing a Smad3-Dependent Epithelial-to-Mesenchymal Transition
Mol. Cancer Res., May 1, 2008; 6(5): 695 - 705.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. L. Chand, G. T. Ooi, C. A. Harrison, A. N. Shelling, and D. M. Robertson
Functional analysis of the human inhibin {alpha} subunit variant A257T and its potential role in premature ovarian failure
Hum. Reprod., December 1, 2007; 22(12): 3241 - 3248.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
J. E Burdette and T. K Woodruff
Activin and estrogen crosstalk regulates transcription in human breast cancer cells
Endocr. Relat. Cancer, September 1, 2007; 14(3): 679 - 689.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Antenos, M. Stemler, I. Boime, and T. K. Woodruff
N-Linked Oligosaccharides Direct the Differential Assembly and Secretion of Inhibin {alpha}- and {beta}A-Subunit Dimers
Mol. Endocrinol., July 1, 2007; 21(7): 1670 - 1684.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
M. I Suszko and T. K Woodruff
Cell-specificity of transforming growth factor-{beta} response is dictated by receptor bioavailability.
J. Mol. Endocrinol., June 1, 2006; 36(3): 591 - 600.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. W. Cook, T. B. Thompson, S. P. Kurup, T. S. Jardetzky, and T. K. Woodruff
Structural Basis for a Functional Antagonist in the Transforming Growth Factor {beta} Superfamily
J. Biol. Chem., December 2, 2005; 280(48): 40177 - 40186.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
S. A. Pangas and M. M. Matzuk
The Art and Artifact of GDF9 Activity: Cumulus Expansion and the Cumulus Expansion-Enabling Factor
Biol Reprod, October 1, 2005; 73(4): 582 - 585.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. I. Suszko, D. M. Balkin, Y. Chen, and T. K. Woodruff
Smad3 Mediates Activin-Induced Transcription of Follicle-Stimulating Hormone {beta}-Subunit Gene
Mol. Endocrinol., July 1, 2005; 19(7): 1849 - 1858.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Society for Endocrinology.